[EN] TRICYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS D'INDOLE TRICYCLIQUES ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:SCHERING CORP
公开号:WO2009152200A1
公开(公告)日:2009-12-17
The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient
[EN] 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS<br/>[FR] DÉRIVÉS D'AZAINDOLES SUBSTITUÉS EN 2 ET 3 DESTINÉS AU TRAITEMENT D'INFECTIONS VIRALES
申请人:SCHERING CORP
公开号:WO2009032125A1
公开(公告)日:2009-03-12
The present invention relates to 2,3-Substituted Azaindole Derivatives, compositions comprising at least one 2,3-Substituted Azaindole Derivatives, and methods of using the 2,3-Substituted Azaindole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
[EN] SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS D'INDOLE SUBSTITUÉS ET PROCÉDÉS D'UTILISATION ASSOCIÉS
申请人:SCHERING CORP
公开号:WO2009032124A1
公开(公告)日:2009-03-12
The present invention relates to Substituted Indole Derivatives, compositions comprising at least one Substituted Indole Derivative, and methods of using these Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
TRICYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF
申请人:Venkatraman Srikanth
公开号:US20110189127A1
公开(公告)日:2011-08-04
The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS
申请人:Anilkumar Gopinadhan N.
公开号:US20100239527A1
公开(公告)日:2010-09-23
The present invention relates to 2,3-Substituted Azaindole Derivatives, compositions comprising at least one 2,3 -Substituted Azaindole Derivatives, and methods of using the 2,3-Substituted Azaindole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.